Transactions
Altasciences acquired by Novo Holdings A/S
Feb. 2021
Client: Altasciences is the leading fully integrated early development CRO, providing a comprehensive range of services, including: Drug discovery, pre-clinical testing, clinical pharmacology and research services, and contract manufacturing (CDMO)
Role: Edgemont acted as co-advisor to Altasciences in the sale of the Company by Audax to Novo Holdings
Location: Laval, QC, Canada
Sector: Pharmaceutical Services
Lead Banker: David Blume
Acquired by
